Results 211 to 220 of about 561,228 (312)

Hospital variation in treatment for synchronous metastatic esophageal and gastric cancer: A nationwide population‐based study in the Netherlands

International Journal of Cancer, EarlyView.
What's New? A range of treatment options exist for metastatic esophageal (EC) and gastric cancer (GC). Which modalities or combination thereof are optimal for these malignancies, however, remains uncertain. Here, the authors examined differences in systemic treatment for metastatic EC and GC across hospitals in the Netherlands.
Julie F. M. Geerts, Pauline A. J. Vissers, Bianca Mostert, Bas P. L. Wijnhoven, Brigitte C. M. Haberkorn, Marie‐Paule G. F. Anten, Camiel Rosman, Geert‐Jan Creemers, Harm Westdorp, Maurice J. C. van der Sangen, Rob H. A. Verhoeven, Grard A. P. Nieuwenhuijzen   +11 more
wiley   +1 more source

Thoracoscopic Resection of an Esophageal Schwannoma Demonstrating a Malignant Pattern on Dual-Time-Point FDG-PET: A Case Report. [PDF]

Surg Case Rep
Harada T, Takemoto K, Okada N, Minagawa N, Matsuno Y, Maeda Y.   +5 more
europepmc   +1 more source

A promising frontier of circulating messenger RNA in liquid biopsy: From mechanisms to clinical applications

International Journal of Cancer, EarlyView.
Abstract Liquid biopsy can revolutionize cancer patient management as repeated sampling allows real‐time monitoring of disease progression and response to treatment. The circulating transcriptome represents a rich source of potential cancer biomarkers, including coding and non‐coding RNAs.
Mengqian Li, Yijin Yu, Guangyue Liu, Shunhong Zhang, Chenchen Luo, Saidi Hu, Siran Wan, Linyong Zhao   +7 more
wiley   +1 more source

Real‐world study on fluoropyrimidine‐related toxicity outcomes in cancer patients with select DPYD variant alleles that received DPYD genotype‐guided dosing

International Journal of Cancer, EarlyView.
What's New? Fluoropyrimidines, a key component of chemotherapy regimens for a variety of solid tumors, can cause severe toxicity. Patients who have specific genetic variants in the DPYD gene, which encodes an enzyme that inactivates fluoropyrimidines, have increased susceptibility to this toxicity.
Sofía L. J. Peeters, Didier Meulendijks, Zerina Kadric, Sara Ibrovic, Geert‐Jan Creemers, Vanja Milosevic, Matthijs van de Poll, Lieke H. J. Simkens, Birgit A. L. M. Deiman, Hans Gelderblom, Henk‐Jan Guchelaar, Anna M. J. Thijs, Maarten J. Deenen   +12 more
wiley   +1 more source

Is endoscopic treatment a useful therapeutic option for esophageal gastrointestinal stromal tumors? [PDF]

World J Gastrointest Endosc
Jabłońska B.
europepmc   +1 more source

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma‐based collection of 77 patients with locally advanced unresectable esophageal cancer

International Journal of Cancer, EarlyView.
What's New? This study introduces a novel approach for detecting locally advanced esophageal carcinoma using cell‐free DNA (cfDNA) analysis through a highly sensitive fragmentome assay. Unlike traditional sequencing‐based methods that are limited by the absence of specific mutations in esophageal tumors, our method offers an alternative by quantifying ...
Anouchka Modesto, Sophie Gibert, Caroline Delmas, David Tougeron, Amaury Paumier, Alexandre Taillez, Samuel Le Sourd, Delphine Argo Leignel, Philippe Ronchin, Ariane Darut Jouve, Véronique Vendrely, Olivier Riou, Jérôme Martin‐Babau, Thomas Leroy, Laurent Quéro, Naïma Hanoun, Pierre Cordelier, Veronica Pezzella, Jean Pierre Delord, Rosine Guimbaud, Elizabeth Moyal, Catherine Seva   +21 more
wiley   +1 more source

Diagnosis and surgical management of a rare esophageal GIST: A case report and review of literature. [PDF]

Int J Surg Case Rep
Zaiem A, Ben Mahmoud A, Sebai A, Atri S, Daghfous A, Kacem JM.   +5 more
europepmc   +1 more source

The role of UPR‐related long noncoding RNAs in development of endocrine resistance in breast cancer

International Journal of Cancer, EarlyView.
Abstract Breast cancer patients who express estrogen receptor α (ER) typically receive endocrine therapy as a first‐line treatment. Most ER‐positive breast cancer patients initially respond to endocrine therapy, but up to 40% of patients develop resistance over time, and the main mechanism is aberrant activation of ER signaling pathways.
Wen Liu, Sahil Gupta, Sanjeev Gupta
wiley   +1 more source

The incidence of esophageal second primary cancer in head and neck cancer patients. [PDF]

Medicine (Baltimore)
Chiou TW, Young CK, Hsu KH, Liao CT, Hu YF, Kang CJ, Huang SF.   +6 more
europepmc   +1 more source

A Case of Malignant Melanoma Metastasis in the Ileal Conduit

IJU Case Reports, EarlyView.
ABSTRACT Introduction Tumor development in the ileal conduit is rare. Herein, we present a case of metastatic malignant melanoma occurring within the ileal conduit 17 years after radical cystectomy. Case Presentation A 76‐year‐old Japanese man, with a history of bladder cancer treated with radical cystectomy and ileal conduit diversion, presented with ...
Noritoshi Shamoto, Yushi Naito, Yuta Sano, Kazuna Matsuo, Satoshi Inoue, Tomoyasu Sano, Tomokazu Kimura, Shohei Ishida, Yoshihisa Matsukawa, Shusuke Akamatsu   +9 more
wiley   +1 more source